Bestell- und Beratungshotline
Tel.: +49 (0)221 788 748-11
E-Mail: service[at]marktforschung.de

Tools
Werbung:
Marktanalyse - Cough, Cold and Allergy (Hay Fever) Remedies - Colombia
Market Direction
Euromonitor
9 / 2010
46 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Kolumbien |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
As an immediate effect of the A1 H1 virus, there was a temporary increase in the demand for cold- fighting drugs in order to counteract the problem. However, this was a temporary trend as the Ministry of Social Care (Ministerio de Salud) ran campaigns to inform the public about what the correct measures were to combat the disease. They showed how Rx medications were the ones that needed to be used.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Child-Specific Cough, Cold and Allergy Remedies, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Cough, Cold and Allergy (hay Fever) Remedies in Colombia
Euromonitor International
September 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Is Affected As GDP Growth Continues To Slow Down
Self-medication Habits Limit the Growth of Consumer Healthcare in Colombia
International Companies Continue To Lead in 2009
Foreign Investment and Local Purchases Strengthen Distribution Channels
Moderate Growth Expected Over the Forecast Period
Key Trends and Developments
Self-medication Remains A Widespread Issue in Colombia
Anti-tobacco Legislation in 2009 Reinforces Law Passed in 2008
Colombian Elders Are Increasingly Targeted by Pharmaceutical Companies
Generics Gain Strength During Economic Downturn
Functional Products Are Expected To Threaten Share of Vitamins and Dietary Supplements
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Switches
Definitions
Summary 1 Research Sources
Biochem Farmaceútica De Colombia SA
Strategic Direction
Key Facts
Summary 2 Biochem Farmaceútica de Colombia SA: Key Facts
Summary 3 Biochem Farmaceútica de Colombia SA: Operational Indicators
Company Background
Production
Summary 4 Biochem Farmacéutica de Colombia SA: Production Statistics 2009
Competitive Positioning
Summary 5 Biochem Farmaceútica de Colombia SA: Competitive Position 2009
Biogen De Colombia Sa, Laboratorios
Strategic Direction
Key Facts
Summary 6 Biogen de Colombia SA, Laboratorios: Key Facts
Summary 7 Biogen de Colombia SA, Laboratorios: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Biogen de Colombia SA, Laboratorios: Competitive Position 2009
Laboratorios California SA
Strategic Direction
Key Facts
Summary 9 Laboratorios California SA: Key Facts
Summary 10 Laboratorios California SA: Operational Indicators
Company Background
Production
Summary 11 Laboratorios California SA: Production Statistics 2009
Competitive Positioning
Summary 12 Laboratorios California SA: Competitive Position 2009
Laboratorios Genéricos Farmacéuticos SA
Strategic Direction
Key Facts
Summary 13 Laboratorios Genéricos Farmacéuticos SA: Key Facts
Summary 14 Laboratorios Genéricos Farmacéuticos SA: Operational Indicators
Company Background
Competitive Positioning
Summary 15 Laboratorios Genéricos Farmacéuticos SA: Competitive Position 2009
Laboratorios Natural Freshly Infabo Ltda
Strategic Direction
Key Facts
Summary 16 Laboratorios Natural Freshly Infabo Ltda: Key Facts
Summary 17 Laboratorios Natural Freshly Infabo Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Laboratorios Natural Freshly Infabo LTDA: Competitive Position 2009
Lafrancol SA
Strategic Direction
Key Facts
Summary 19 Lafrancol SA: Key Facts
Summary 20 Lafrancol SA: Operational Indicators
Company Background
Production
Summary 21 Lafrancol SA: Production Statistics 2009
Competitive Positioning
Summary 22 Lafrancol SA: Competitive Position 2009
Omnilife Manufactura De Colombia Ltda
Strategic Direction
Key Facts
Summary 23 Omnilife Manufactura de Colombia Ltda: Key Facts
Summary 24 Omnilife Manufactura de Colombia Ltda: Operational Indicators
Company Background
Production
Summary 25 Omnilife Manufactura de Colombia Ltda: Production Statistics 2009
Competitive Positioning
Summary 26 Omnilife Manufactura de Colombia Ltda: Competitive Position 2009
Tecnoquímicas SA
Strategic Direction
Key Facts
Summary 27 Tecnoquímicas SA: Key Facts
Summary 28 Tecnoquímicas SA: Operational Indicators
Company Background
Production
Summary 29 Tecnoquímicas SA: Production Statistics 2009
Competitive Positioning
Summary 30 Tecnoquímicas SA: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009
Table 14 Sales of Decongestants by Type: Value 2004-2009
Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009
Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014
Euromonitor International
September 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Is Affected As GDP Growth Continues To Slow Down
Self-medication Habits Limit the Growth of Consumer Healthcare in Colombia
International Companies Continue To Lead in 2009
Foreign Investment and Local Purchases Strengthen Distribution Channels
Moderate Growth Expected Over the Forecast Period
Key Trends and Developments
Self-medication Remains A Widespread Issue in Colombia
Anti-tobacco Legislation in 2009 Reinforces Law Passed in 2008
Colombian Elders Are Increasingly Targeted by Pharmaceutical Companies
Generics Gain Strength During Economic Downturn
Functional Products Are Expected To Threaten Share of Vitamins and Dietary Supplements
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Switches
Definitions
Summary 1 Research Sources
Biochem Farmaceútica De Colombia SA
Strategic Direction
Key Facts
Summary 2 Biochem Farmaceútica de Colombia SA: Key Facts
Summary 3 Biochem Farmaceútica de Colombia SA: Operational Indicators
Company Background
Production
Summary 4 Biochem Farmacéutica de Colombia SA: Production Statistics 2009
Competitive Positioning
Summary 5 Biochem Farmaceútica de Colombia SA: Competitive Position 2009
Biogen De Colombia Sa, Laboratorios
Strategic Direction
Key Facts
Summary 6 Biogen de Colombia SA, Laboratorios: Key Facts
Summary 7 Biogen de Colombia SA, Laboratorios: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Biogen de Colombia SA, Laboratorios: Competitive Position 2009
Laboratorios California SA
Strategic Direction
Key Facts
Summary 9 Laboratorios California SA: Key Facts
Summary 10 Laboratorios California SA: Operational Indicators
Company Background
Production
Summary 11 Laboratorios California SA: Production Statistics 2009
Competitive Positioning
Summary 12 Laboratorios California SA: Competitive Position 2009
Laboratorios Genéricos Farmacéuticos SA
Strategic Direction
Key Facts
Summary 13 Laboratorios Genéricos Farmacéuticos SA: Key Facts
Summary 14 Laboratorios Genéricos Farmacéuticos SA: Operational Indicators
Company Background
Competitive Positioning
Summary 15 Laboratorios Genéricos Farmacéuticos SA: Competitive Position 2009
Laboratorios Natural Freshly Infabo Ltda
Strategic Direction
Key Facts
Summary 16 Laboratorios Natural Freshly Infabo Ltda: Key Facts
Summary 17 Laboratorios Natural Freshly Infabo Ltda: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 18 Laboratorios Natural Freshly Infabo LTDA: Competitive Position 2009
Lafrancol SA
Strategic Direction
Key Facts
Summary 19 Lafrancol SA: Key Facts
Summary 20 Lafrancol SA: Operational Indicators
Company Background
Production
Summary 21 Lafrancol SA: Production Statistics 2009
Competitive Positioning
Summary 22 Lafrancol SA: Competitive Position 2009
Omnilife Manufactura De Colombia Ltda
Strategic Direction
Key Facts
Summary 23 Omnilife Manufactura de Colombia Ltda: Key Facts
Summary 24 Omnilife Manufactura de Colombia Ltda: Operational Indicators
Company Background
Production
Summary 25 Omnilife Manufactura de Colombia Ltda: Production Statistics 2009
Competitive Positioning
Summary 26 Omnilife Manufactura de Colombia Ltda: Competitive Position 2009
Tecnoquímicas SA
Strategic Direction
Key Facts
Summary 27 Tecnoquímicas SA: Key Facts
Summary 28 Tecnoquímicas SA: Operational Indicators
Company Background
Production
Summary 29 Tecnoquímicas SA: Production Statistics 2009
Competitive Positioning
Summary 30 Tecnoquímicas SA: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2004-2009
Table 13 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2004-2009
Table 14 Sales of Decongestants by Type: Value 2004-2009
Table 15 Sales of Decongestants by Type: % Value Growth 2004-2009
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2004-2009
Table 17 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2004-2009
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2005-2009
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2006-2009
Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2009-2014
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2009-2014
- Cough, Cold and Allergy (Hay Fever) Remedies in Australia
- Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
- Cough, Cold and Allergy (Hay Fever) Remedies in Egypt
- Cough, Cold and Allergy (Hay Fever) Remedies in Romania
- Cough, Cold and Allergy (Hay Fever) Remedies in Saudi Arabia
- Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
- Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia
- Cough, Cold and Allergy (Hay Fever) Remedies in Kenya
- Cough, Cold and Allergy (Hay Fever) Remedies in Pakistan
- Cough, Cold and Allergy (Hay Fever) Remedies in Portugal
- Allergies – Pipeline Review, H2 2012
- Cough, Cold and Allergy (Hay Fever) Remedies in Iran
- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Cough, Cold and Allergy (Hay Fever) Remedies in the Netherlands
- Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan
- Cough, Cold and Allergy (Hay Fever) Remedies in Vietnam
- Peanut Allergy – Pipeline Review, H2 2012
- Pollen Allergy – Pipeline Review, H2 2012
- Cough, Cold and Allergy (Hay Fever) Remedies in Algeria
- Cough, Cold and Allergy (Hay Fever) Remedies in Austria
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien:


